Gabexate Mesilate

甲磺酸加贝酯

Report date: 2023/02/21 20:00:25
NME

Base Information

Drug NameGabexate Mesilate
Drug Alias NamegabexateGabexate MesylategabexatumgabexatoFOY
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor inhibitors
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsDisseminated Intravascular CoagulationPancreatitisLiver Diseases
Global Approved IndicationsPancreatitis
Approved Indications in ChinaPancreatitis
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritorySouth KoreaMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYonsei University
China Registration ClassN/A

Develop Information

Active CompaniesAlfresa PharmaChangzhou Jinyuan Pharmaceutical Manufacturing Co Ltd
Inactive CompaniesYonsei University
Active IndicationsDisseminated Intravascular CoagulationPancreatitis
Inactive IndicationsLiver Diseases

Other Information

ATC CodeB02AB
Related LinksWikipediaKEGG